AMGEN INC (1AMGN.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1AMGN - US0311621009 - Common Stock
278.45 EUR
-16.45 (-5.58%)
Overall 1AMGN gets a fundamental rating of 5 out of 10. We evaluated 1AMGN against 81 industry peers in the Biotechnology industry. 1AMGN scores excellent on profitability, but there are concerns on its financial health. 1AMGN is not valued too expensively and it also shows a decent growth rate. Finally 1AMGN also has an excellent dividend rating.
1. Profitability
1.1 Basic Checks
1AMGN had positive earnings in the past year.
In the past year 1AMGN had a positive cash flow from operations.
1AMGN had positive earnings in each of the past 5 years.
1AMGN had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
1AMGN has a better Return On Assets (7.77%) than 80.72% of its industry peers.
With an excellent Return On Equity value of 72.82%, 1AMGN belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
With an excellent Return On Invested Capital value of 15.39%, 1AMGN belongs to the best of the industry, outperforming 91.57% of the companies in the same industry.
1AMGN had an Average Return On Invested Capital over the past 3 years of 13.04%. This is in line with the industry average of 11.80%.
The 3 year average ROIC (13.04%) for 1AMGN is below the current ROIC(15.39%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.77% | ||
| ROE | 72.82% | ||
| ROIC | 15.39% |
ROA(3y)7.14%
ROA(5y)8.52%
ROE(3y)118.78%
ROE(5y)104.3%
ROIC(3y)13.04%
ROIC(5y)14.18%
1.3 Margins
With an excellent Profit Margin value of 19.47%, 1AMGN belongs to the best of the industry, outperforming 81.93% of the companies in the same industry.
1AMGN's Profit Margin has declined in the last couple of years.
1AMGN has a better Operating Margin (33.57%) than 89.16% of its industry peers.
In the last couple of years the Operating Margin of 1AMGN has declined.
1AMGN has a Gross Margin of 72.06%. This is in the better half of the industry: 1AMGN outperforms 62.65% of its industry peers.
1AMGN's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 33.57% | ||
| PM (TTM) | 19.47% | ||
| GM | 72.06% |
OM growth 3Y-6.36%
OM growth 5Y-7.03%
PM growth 3Y-18.6%
PM growth 5Y-18.28%
GM growth 3Y-2.94%
GM growth 5Y-3.32%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), 1AMGN is creating value.
1AMGN has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, 1AMGN has less shares outstanding
1AMGN has a better debt/assets ratio than last year.
2.2 Solvency
The Debt to FCF ratio of 1AMGN is 4.28, which is a neutral value as it means it would take 1AMGN, 4.28 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of 1AMGN (4.28) is better than 78.31% of its industry peers.
A Debt/Equity ratio of 5.45 is on the high side and indicates that 1AMGN has dependencies on debt financing.
1AMGN has a worse Debt to Equity ratio (5.45) than 67.47% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.45 | ||
| Debt/FCF | 4.28 | ||
| Altman-Z | N/A |
ROIC/WACC1.81
WACC8.49%
2.3 Liquidity
A Current Ratio of 1.28 indicates that 1AMGN should not have too much problems paying its short term obligations.
1AMGN's Current ratio of 1.28 is on the low side compared to the rest of the industry. 1AMGN is outperformed by 67.47% of its industry peers.
1AMGN has a Quick Ratio of 1.28. This is a bad value and indicates that 1AMGN is not financially healthy enough and could expect problems in meeting its short term obligations.
1AMGN has a worse Quick ratio (0.99) than 68.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.28 | ||
| Quick Ratio | 0.99 |
3. Growth
3.1 Past
1AMGN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.79%, which is quite good.
Measured over the past 5 years, 1AMGN shows a small growth in Earnings Per Share. The EPS has been growing by 5.97% on average per year.
1AMGN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.56%.
1AMGN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.43% yearly.
EPS 1Y (TTM)13.79%
EPS 3Y5.02%
EPS 5Y5.97%
EPS Q2Q%1.08%
Revenue 1Y (TTM)10.56%
Revenue growth 3Y8.76%
Revenue growth 5Y7.43%
Sales Q2Q%12.4%
3.2 Future
1AMGN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.48% yearly.
Based on estimates for the next years, 1AMGN will show a small growth in Revenue. The Revenue will grow by 3.55% on average per year.
EPS Next Y9.43%
EPS Next 2Y6.17%
EPS Next 3Y5.25%
EPS Next 5Y4.48%
Revenue Next Year9.42%
Revenue Next 2Y5.5%
Revenue Next 3Y4.54%
Revenue Next 5Y3.55%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 14.91, the valuation of 1AMGN can be described as correct.
Based on the Price/Earnings ratio, 1AMGN is valued cheaper than 86.75% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.77. 1AMGN is valued slightly cheaper when compared to this.
Based on the Price/Forward Earnings ratio of 14.60, the valuation of 1AMGN can be described as correct.
Based on the Price/Forward Earnings ratio, 1AMGN is valued cheaply inside the industry as 93.98% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 23.35. 1AMGN is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.91 | ||
| Fwd PE | 14.6 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, 1AMGN is valued cheaply inside the industry as 80.72% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, 1AMGN is valued cheaper than 90.36% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.77 | ||
| EV/EBITDA | 12.5 |
4.3 Compensation for Growth
1AMGN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
1AMGN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.58
PEG (5Y)2.5
EPS Next 2Y6.17%
EPS Next 3Y5.25%
5. Dividend
5.1 Amount
1AMGN has a Yearly Dividend Yield of 3.11%.
Compared to an average industry Dividend Yield of 0.74, 1AMGN pays a better dividend. On top of this 1AMGN pays more dividend than 97.59% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.00, 1AMGN pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.11% |
5.2 History
The dividend of 1AMGN is nicely growing with an annual growth rate of 9.41%!
Dividend Growth(5Y)9.41%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
1AMGN pays out 17.20% of its income as dividend. This is a sustainable payout ratio.
The dividend of 1AMGN is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP17.2%
EPS Next 2Y6.17%
EPS Next 3Y5.25%
BIT:1AMGN (12/8/2025, 7:00:00 PM)
278.45
-16.45 (-5.58%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners83.83%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap149.94B
Revenue(TTM)35.97B
Net Income(TTM)7.00B
Analysts72.2
Price Target289.78 (4.07%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.11% |
Yearly Dividend7.7
Dividend Growth(5Y)9.41%
DP17.2%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.96%
Min EPS beat(2)10.28%
Max EPS beat(2)11.64%
EPS beat(4)4
Avg EPS beat(4)9.04%
Min EPS beat(4)2.49%
Max EPS beat(4)11.73%
EPS beat(8)7
Avg EPS beat(8)5.13%
EPS beat(12)10
Avg EPS beat(12)4.44%
EPS beat(16)14
Avg EPS beat(16)4.21%
Revenue beat(2)2
Avg Revenue beat(2)2.59%
Min Revenue beat(2)0.68%
Max Revenue beat(2)4.49%
Revenue beat(4)3
Avg Revenue beat(4)1.17%
Min Revenue beat(4)-0.84%
Max Revenue beat(4)4.49%
Revenue beat(8)3
Avg Revenue beat(8)-0.21%
Revenue beat(12)4
Avg Revenue beat(12)-0.48%
Revenue beat(16)5
Avg Revenue beat(16)-0.54%
PT rev (1m)5.64%
PT rev (3m)3.43%
EPS NQ rev (1m)0.07%
EPS NQ rev (3m)-11.17%
EPS NY rev (1m)1.12%
EPS NY rev (3m)2.12%
Revenue NQ rev (1m)-0.04%
Revenue NQ rev (3m)1.93%
Revenue NY rev (1m)1.86%
Revenue NY rev (3m)2.89%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.91 | ||
| Fwd PE | 14.6 | ||
| P/S | 4.88 | ||
| P/FCF | 13.77 | ||
| P/OCF | 13.38 | ||
| P/B | 18.26 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.5 |
EPS(TTM)18.67
EY6.7%
EPS(NY)19.08
Fwd EY6.85%
FCF(TTM)20.22
FCFY7.26%
OCF(TTM)20.81
OCFY7.47%
SpS57.04
BVpS15.25
TBVpS-51.05
PEG (NY)1.58
PEG (5Y)2.5
Graham Number80.04
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.77% | ||
| ROE | 72.82% | ||
| ROCE | 17.67% | ||
| ROIC | 15.39% | ||
| ROICexc | 17.86% | ||
| ROICexgc | 61.56% | ||
| OM | 33.57% | ||
| PM (TTM) | 19.47% | ||
| GM | 72.06% | ||
| FCFM | 35.46% |
ROA(3y)7.14%
ROA(5y)8.52%
ROE(3y)118.78%
ROE(5y)104.3%
ROIC(3y)13.04%
ROIC(5y)14.18%
ROICexc(3y)15.77%
ROICexc(5y)17.27%
ROICexgc(3y)75.76%
ROICexgc(5y)77.1%
ROCE(3y)14.97%
ROCE(5y)16.28%
ROICexgc growth 3Y3.26%
ROICexgc growth 5Y-18.2%
ROICexc growth 3Y-8.67%
ROICexc growth 5Y-7.85%
OM growth 3Y-6.36%
OM growth 5Y-7.03%
PM growth 3Y-18.6%
PM growth 5Y-18.28%
GM growth 3Y-2.94%
GM growth 5Y-3.32%
F-Score7
Asset Turnover0.4
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.45 | ||
| Debt/FCF | 4.28 | ||
| Debt/EBITDA | 2.97 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 74.3% | ||
| Profit Quality | 182.08% | ||
| Current Ratio | 1.28 | ||
| Quick Ratio | 0.99 | ||
| Altman-Z | N/A |
F-Score7
WACC8.49%
ROIC/WACC1.81
Cap/Depr(3y)24.77%
Cap/Depr(5y)23.42%
Cap/Sales(3y)3.59%
Cap/Sales(5y)3.31%
Profit Quality(3y)165.92%
Profit Quality(5y)155.23%
High Growth Momentum
Growth
EPS 1Y (TTM)13.79%
EPS 3Y5.02%
EPS 5Y5.97%
EPS Q2Q%1.08%
EPS Next Y9.43%
EPS Next 2Y6.17%
EPS Next 3Y5.25%
EPS Next 5Y4.48%
Revenue 1Y (TTM)10.56%
Revenue growth 3Y8.76%
Revenue growth 5Y7.43%
Sales Q2Q%12.4%
Revenue Next Year9.42%
Revenue Next 2Y5.5%
Revenue Next 3Y4.54%
Revenue Next 5Y3.55%
EBIT growth 1Y93.73%
EBIT growth 3Y1.84%
EBIT growth 5Y-0.13%
EBIT Next Year42.82%
EBIT Next 3Y11.34%
EBIT Next 5Y7.32%
FCF growth 1Y36%
FCF growth 3Y7.44%
FCF growth 5Y4.03%
OCF growth 1Y24.04%
OCF growth 3Y7.45%
OCF growth 5Y4.66%
AMGEN INC / 1AMGN.MI FAQ
Can you provide the ChartMill fundamental rating for AMGEN INC?
ChartMill assigns a fundamental rating of 5 / 10 to 1AMGN.MI.
Can you provide the valuation status for AMGEN INC?
ChartMill assigns a valuation rating of 6 / 10 to AMGEN INC (1AMGN.MI). This can be considered as Fairly Valued.
How profitable is AMGEN INC (1AMGN.MI) stock?
AMGEN INC (1AMGN.MI) has a profitability rating of 7 / 10.
What is the valuation of AMGEN INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for AMGEN INC (1AMGN.MI) is 14.91 and the Price/Book (PB) ratio is 18.26.
What is the financial health of AMGEN INC (1AMGN.MI) stock?
The financial health rating of AMGEN INC (1AMGN.MI) is 3 / 10.